LIDOCAINE HYDROCHLORIDE AND EPIN. Key specifications include protective_storage_feature: SUBJECT TO DAMAGE BY FREEZING, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 50, primary_container_content_quantity: 1.700 MILLILITERS, part_name_assigned_by_controlling_agency: LIDOCAINE HCL 2% EPINEPHRINE 0.002% RATIO OF 1:50000 50S. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System under NSN 6505-01-576-2767, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| protective_storage_feature | SUBJECT TO DAMAGE BY FREEZING |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 50 |
| primary_container_content_quantity | 1.700 MILLILITERS |
| part_name_assigned_by_controlling_agency | LIDOCAINE HCL 2% EPINEPHRINE 0.002% RATIO OF 1:50000 50S |
| NSN | 6505-01-576-2767 |
| SPECIAL FEATURES | 2% LIDOCAINE HYDROCHLORIDE AND 0.002% EPINEPHRINE; RATIO OF 1: 50,000; 1.7 ML CARTRIDGE; PACKAGE OF 50 CARTRIDGES |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | CARTRIDGE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LIDOCAINE HCL 2% EPINEPHRINE 0.002% RATIO OF 1:50000 50S |
| PROTECTIVE STORAGE FEATURE | SUBJECT TO DAMAGE BY FREEZING |
| PRIMARY CONTAINER CONTENT QUANTITY | 1.700 MILLILITERS |
| TOTAL PRIMARY CONTAINER QUANTITY | 50 |